tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (TSE:DRUG)
:DRUG
Canadian Market

Bright Minds Biosciences (DRUG) Financial Statements

Compare
65 Followers

Bright Minds Biosciences Financial Overview

Bright Minds Biosciences's market cap is currently C$275.04M. The company's EPS TTM is C$-0.42; its P/E ratio is ―; Bright Minds Biosciences is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is C$-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -73.36KC$ -72.45KC$ -6.04KC$ 0.00C$ 0.00
Operating IncomeC$ -2.81MC$ -7.37MC$ -14.74MC$ -8.76MC$ -469.36K
EBITDAC$ -2.72MC$ -7.28MC$ -14.96MC$ 0.00C$ 0.00
Net IncomeC$ -2.80MC$ -7.37MC$ -15.19MC$ -8.52MC$ -485.94K
Balance Sheet
Cash & Short-Term InvestmentsC$ 5.72MC$ 6.75MC$ 11.63MC$ 19.76MC$ 799.93K
Total AssetsC$ 6.10MC$ 6.88MC$ 12.09MC$ 20.04MC$ 880.22K
Total DebtC$ 118.96KC$ 73.55KC$ 139.91KC$ 0.00C$ 0.00
Net DebtC$ -5.60MC$ -6.67MC$ -11.49MC$ -19.76MC$ -799.93K
Total LiabilitiesC$ 568.26KC$ 280.86KC$ 1.54MC$ 638.57KC$ 150.92K
Stockholders' EquityC$ 5.54MC$ 6.60MC$ 10.54MC$ 19.40MC$ 729.29K
Cash Flow
Free Cash FlowC$ -1.85MC$ -7.02MC$ -13.59MC$ -7.32MC$ -288.39K
Operating Cash FlowC$ -1.85MC$ -7.02MC$ -13.59MC$ -7.32MC$ -288.39K
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 810.57KC$ 2.19MC$ 5.20MC$ 26.06MC$ 1.01M
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Bright Minds Biosciences Debt to Assets

Bright Minds Biosciences Cash Flow

Bright Minds Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis